ESH Acquisition Corp. (ESHA): Nasdaq/NYSE listing notice — ESH Acquisition Corp. receives Nasdaq MVLS deficiency notice; 180-day cure period

ESH Acquisition Corp.

On April 11, 2025, Nasdaq notified ESHA that its Class A Common Stock MVLS was below $50M for 30 consecutive business days.
Company has until October 8, 2025 to regain compliance by closing MVLS at or above $50M for 10 consecutive business days.
If compliance not regained, ESHA may transfer to Nasdaq Capital Market or face delisting and possible appeal.
Trading under symbol 'ESHA' continues uninterrupted; company is seeking to maintain listing.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ESH Acquisition Corp. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5450(b)(2)(A)

Exact text from the filing

April 11, 2025, ESH Acquisition Corp. (the “Company”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that, for the prior 30 consecutive business days (through April 10, 2025), the closing market value of listed securities (MVLS) of the Company’s Class A Common Stock (“Class A Shares”), had been below the minimum of $50 million required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A). The notice stated that the Company would be afforded 180 calendar days (until October 8, 2025) to regain co

View on SEC.gov

93 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

ESH Acquisition Corp. filing history →

Source: SEC EDGAR

accession 0001213900-25-032972

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.